L716-0314 Screening compound: 4-({3-[(4-chlorophenyl)sulfanyl]pyrazin-2-yl}oxy)-N-[3-(4-methylpiperazin-1-yl)propyl]benzamide

L716-0314 Screening compound: 4-({3-[(4-chlorophenyl)sulfanyl]pyrazin-2-yl}oxy)-N-[3-(4-methylpiperazin-1-yl)propyl]benzamide
L716-0314 Screening compound: 4-({3-[(4-chlorophenyl)sulfanyl]pyrazin-2-yl}oxy)-N-[3-(4-methylpiperazin-1-yl)propyl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L716-0314
4-({3-[(4-chlorophenyl)sulfanyl]pyrazin-2-yl}oxy)-N-[3-(4-methylpiperazin-1-yl)propyl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L716-0314

Molecular Formula

C25H28ClN5O2S (C25 H28 ClN5 O2 S)

Compound Name

4-({3-[(4-chlorophenyl)sulfanyl]pyrazin-2-yl}oxy)-N-[3-(4-methylpiperazin-1-yl)propyl]benzamide

IUPAC name

4-({3-[(4-chlorophenyl)sulfanyl]pyrazin-2-yl}oxy)-N-[3-(4-methylpiperazin-1-yl)propyl]benzamide

SMILES

CN1CCN(CCCNC(c(cc2)ccc2Oc2nccnc2Sc(cc2)ccc2Cl)=O)CC1

InChI

InChI=1S/C25H28ClN5O2S/c1-30-15-17-31(18-16-30)14-2-11-27-23(32)19-3-7-21(8-4-19)33-24-25(29-13-12-28-24)34-22-9-5-20(26)6-10-22/h3-10,12-13H,2,11,14-18H2,1H3,(H,27,32)

InChI Key

QVEDZZWHHUEUSA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15133791

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

498.05

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.831

Distribution Coefficient, logD

2.681

Water Solubility, LogSw

-4.47

Polar Surface Area

57.413

Acid Dissociation Constant (pKa)

14.51

Base Dissociation Constant (pKb)

8.52

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

32.00

L716-0314 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L716-0314 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L716-0314?
Check Price and Availability of L716-0314, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L716-0314 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L716-0314
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L716-0314
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L716-0314 available by request